Ticker > Company >

Paramesu Biotech share price

Paramesu Biotech Ltd.

 244   0   0

The company is currently not listed and is under IPO, so all the data might not be available.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Ratios

Sales Growth

1 Year0.63%
3 YearNA
5 YearNA

Profit Growth

1 Year24.02%
3 YearNA
5 YearNA

ROE%

1 Year26.36%
3 Year29.27%

ROCE %

1 Year21.36%
3 Year25.01%

Debt/Equity

1.1892

Price to Cash Flow

0

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

0

 Strengths

  • Company has been maintaining healthy ROE of 29.2709333333333% over the past 3 years.
  • Company has been maintaining healthy ROCE of 25.0139333333333% over the past 3 years.
  • The company has an efficient Cash Conversion Cycle of 0 days.

 Limitations

  • The company has shown a poor profit growth of 0% for the Past 3 years.
  • The company has shown a poor revenue growth of 0% for the Past 3 years.
  • Company has low Interest coverage ratio of 0.
  • The company has a low EBITDA margin of 0% over the past 5 years.

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024
Net Sales 494.91 623.93 627.85
Total Expenditure 435.16 567.2 551.3
Operating Profit 59.75 56.73 76.55
Other Income 1.7 1.42 1.44
Interest 10.06 8.55 15.26
Depreciation 5.38 5.57 8.3
Exceptional Items 0 0 0
Profit Before Tax 46.01 44.02 54.43
Tax 12.04 11.5 14.09
Net Profit 33.97 32.52 40.34
Adjusted EPS (Rs.) 1.29 1.24 1.54

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 26.26 26.26 26.26
Total Reserves 74.69 106.7 146.87
Borrowings 41.37 88.77 101.34
Other N/C liabilities 9.77 11.26 15.67
Current liabilities 86.79 86.18 149.55
Total Liabilities 238.88 319.17 439.68
Assets
Net Block 130.41 127.55 241.62
Capital WIP 2.87 65.98 23.89
Intangible WIP 0 0 0
Investments 0 0 0
Loans & Advances 2.38 2.63 3.35
Other N/C Assets 0.19 0.28 0.21
Current Assets 103.03 122.74 170.61
Total Assets 238.88 319.17 439.68
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2023 Mar 2024
Profit from operations 44.02 54.43
Adjustment 13.72 23.4
Changes in Assets & Liabilities -32.64 -34.85
Tax Paid -9.96 -10.8
Operating Cash Flow 15.13 32.18
Investing Cash Flow -65.41 -79.89
Financing Cash Flow 50.04 50.07
Net Cash Flow -0.24 2.35

Corporate Actions

Last Updated on:
Brief about Paramesu Biotech
X